Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
GLPG-3667 by Galapagos for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
GLPG-3667 is under clinical development by Galapagos and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to GlobalData,...
Data Insights
GLPG-3667 by Galapagos for Ulcerative Colitis: Likelihood of Approval
GLPG-3667 is under clinical development by Galapagos and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I...